PTC Therapeutics: UBS raises target price to $90 from $80
PTCT•UBS raised its target price for PTC Therapeutics to $90 from $80.
Related News
Alnylam Pharmaceuticals: UBS cuts target price to $354 from $550
ALNY•
Unum Group declares quarterly dividend of $0.505 per share
UNM•
Colgate-Palmolive target price cut to $106 from $109 by UBS
CL•
Nasdaq trade halt continues; reason not available at 10:27 a.m.
UCFI•
BridgeBio Pharma, Inc.: UBS raises target price to $92 from $82
BBIO•